Translational science and the hidden research system in universities and academic hospitals: A case study

Social Science and Medicine

Volumn 72, Issue 4, 2011, Pages 537-544

  Lander, Bryn ^a   Atkinson Grosjean, Janet ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Biomedical innovation system; Canada; Clinician scientists; Hidden research system; Innate immunity; IRAK 4; Translational science

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE;

HOSPITAL SECTOR; INNOVATION; MEDICINE; PRIVATE SECTOR; PUBLIC SECTOR; UNIVERSITY SECTOR;

ARTICLE; CANADA; GENETIC DISORDER; GENOMICS; HIDDEN RESEARCH SYSTEM; IMMUNOPATHOLOGY; INNATE IMMUNITY; IRAK 4 DEFICIENCY; SCIENTIST; THEORY-PRACTICE RELATIONSHIP; TRANSLATIONAL RESEARCH; UNIVERSITY HOSPITAL; HEALTH CARE PLANNING; HEALTH SERVICES RESEARCH; HUMAN; MASS COMMUNICATION; ORGANIZATION AND MANAGEMENT; PUBLIC RELATIONS; UNIVERSITY;

CANADA;

ACADEMIC MEDICAL CENTERS; CANADA; DIFFUSION OF INNOVATION; HEALTH RESOURCES; HUMANS; INTERINSTITUTIONAL RELATIONS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; ORGANIZATIONAL CASE STUDIES; PRIVATE SECTOR; PUBLIC SECTOR; TRANSLATIONAL RESEARCH; UNIVERSITIES;

EID: 79954440618     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2010.11.019     Document Type: Article

References (46)

1. Abreu M.T., Arditi M. Innate immunity and toll-like receptors: clinical implications of basic science research. The Journal of Pediatrics 2004, 144(4):421-429.
2. Atkinson-Grosjean J. Public science, private interests: Culture and commerce in Canada's networks of centres of excellence 2006, University of Toronto Press, Toronto.
3. Ben-David J. Roles and innovations in medicine. The American Journal of Sociology 1960, 65(6):557-568.
4. von Bernuth H., Picard C., Jin Z., Pankla R., Xiao H., Ku C.L., et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008, 321(5889):691-696.
5. Brown K.L., Falsafi R., Kum W., Hamill P., Gardy J.L., Davidson D.J., et al. Robust TLR 4-induced gene expression patterns are not an accurate indicator of human immunity. Journal of Translational Medicine 2010, 8(1):6.
6. Cambrosio A., Keating P. A matter of FACS: constituting novel entities in immunology. Medical Anthropology Quarterly 1992, 6(4):362-384.
7. Cambrosio A., Keating P. Exquisite specificity: The monoclonal antibody revolution 1995, Oxford University Press, New York.
8. Currie A.J., Davidson D.J., Reid G.S.D., Bharya S., MacDonald K.L., Devon R.S., et al. Primary immunodeficiency to pneumococcal infection due to a defect in toll-like receptor signaling. The Journal of Pediatrics 2004, 144(4):512-518.
9. Djellal F., Gallouj F. Mapping innovation dynamics in hospitals. Research Policy 2005, 34:817-835.
10. Etzkowitz H., Webster A., Gebhardt C., Terra B.R.C. The future of the university and the university of the future: evolution of ivory tower to entrepreneurial paradigm. Research Policy 2000, 29:313-330.
11. Fujimura J.H. Constructing 'Do-Able' problems in cancer research: articulating alignment. Social Studies of Science 1987, 17(No. 2 (May, 1987)):257-293.
12. Fujimura J.H. Crafting science: A sociohistory of the quest for a genetics of cancer 1996, Harvard University Press, Cambridge.
13. Gelijns A.C., Rosenberg N. The dynamics of technological change in medicine. Health Affairs 1994, 13(3):28-47.
14. Gelijns A.C., Zivin J.G., Nelson R.R. Uncertainty and technological change in medicine. Journal of Health Politics, Policy and Law 2001, 25(5):913-924.
15. Gieryn T.F. Boundary work and the demarcation of science from nonscience: strains and interests in professional ideologies of scientists. American Sociological Review 1983, 48:781-795.
16. Good R.A. The Minnesota scene: A crucial portal of entry to modern cellular immunology. The immunologic revolution: Facts and witnesses 1994, 105-168. CRC Press, Inc., United States of America. A. Szentivanyi, H. Friedman (Eds.).
17. Hicks D., Katz J.S. Hospitals: the hidden research system. Science and Public Policy 1996, 23(5):297-304.
18. Hippel E.v. The sources of innovation 1988, Oxford University Press, New York.
19. Hirschfeld A.F., Bettinger J.A., Victor R.E., Davidson D.J., Currie A.J., Ansermino J.M., et al. Prevalence of toll-like receptor signaling defects in apparently healthy children who developed invasive pneumococcal infection. Clinical Immunology 2007, 122(3):271-278.
20. Hopkins M. The hidden research system: the evolution of cytogenetic testing in the National Health Service. Science as Culture 2006, 15(3):253-276.
21. Keating P., Cambrosio A. Biomedical platforms: Realigning the normal and the pathological in late 20th century medicine 2003, The MIT Press, Cambridge.
22. Kerner J.F. Knowledge translation versus knowledge integration: a 'funder's' perspective. Journal of Continuing Education in the Health Professions 2006, 26(1):72-80.
23. Khoury M.J., Gwinn M., Yoon P.W., Dowling N., Moore C.A., Bradley L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?. Genetics in Medicine 2007, 9(10):665-674. [review].
24. Kline S., Rosenberg N. An overview of innovation. The positive sum strategy: Harnessing technology for economic growth 1986, National Academies Press, Washington, D.C. R. Landau, N. Rosenberg (Eds.).
25. Knorr-Cetina K. Epistemic cultures: How the sciences make knowledge 1999, Harvard University Press, Cambridge, MA.
26. Kroker K., Jennifer K., Mazumdar P.M.H. Crafting immunity: working histories of clinical immunology. The history of medicine in context 2008, Ashgate, Aldershot.
27. Ku C.L., von Bernuth H., Picard C., Zhang S.Y., Chang H.H., Yang K., et al. Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity. Journal of Experimental Medicine 2007, 204(10):2407-2422.
28. Kuhn T.S. The structure of scientific revolutions 1962, University of Chicago Press, Chicago, Il. 1st ed.
29. Löwy I. The impact of medical practice on biomedical research: the case of human leucocyte antigens studies. Minerva 1987, 25(1):171-200.
30. Löwy Ilana Between bench and bedside: Science, healing and Interleukin -2 in a cancer ward 1996, HarvardUniversity Press, Cambridge.
31. Lundvall B.A. Working paper-national innovation system: Analytical focusing device and policy learning tool 2007, Swedish Institute for Growth Policy Studies, Ostersund, Sweden.
32. Martin P., Brown N., Kraft A. From bedside to bench? Communities of promise, translational research and the making of blood stem cells. Science as Culture 2008, 17(1):29-41.
33. MRC's translational research strategy Medical Research Council, (Accessed 13.04.2010). http://www.mrc.ac.uk/Ourresearch/ResearchInitiatives/Translationalresearch/index.htm.
34. Nelson R., Winter S.G. In search of a useful theory in innovation. Research Policy 1977, 6:36-76.
35. Nielson K.H. Enacting the social relations of science: historical (anti-)boundary-work of Danish science journalist Børge Michelsen. Public Understanding of Science 2008, 17(No. 2):171-188.
36. Picard C., Puel A., Bonnet M., Ku C., Bustamante J., Yang K., et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003, 299:2076-2079.
37. Rosenberg N. Some critical episodes in the progress of medical innovation: an anglo-american perspective. Research Policy 2009, 38:234-242.
38. Sharif N. Emergence and development of the national innovation systems concept. Research Policy 2006, 35:745-766.
39. Star S.L., James R.G. Institutional ecology, 'translations' and boundary objects: amateurs and professionals in Berkeley's museum of vertebrate zoology, 1907-39. Social Studies of Science 1989, 19:387-420.
40. Stokes D.E. Pasteur's quadrant: Basic science and technological innovation 1997, Brookings Institute Press, Washington, D.C.
41. Sturdy S. Knowing cases: biomedicine in Edinburgh, 1887-1920. Social Studies of Science 2007, 37(5):659-689.
42. Swan J., Goussevskaia A., Newell S., Robertson M., Bresnen M., Obembe A. Modes of organizing biomedical innovation in the UK and US and the role of integrative and relational capabilities. Research Policy 2007, 36:529-547.
43. Turvey S.E., Hawn T.R. Towards subtlety: understanding the role of toll-like receptor signaling in susceptibility to human infections. Clinical Immunology 2006.
44. Wainwright S.P., Clare W., Mike M., Bobbie F., Cribb A. From bedside to bench? Biomedical scientists expectations of stem cell science as a future therapy for diabetes. Social Science & Medicine 2006, 63:2052-2064.
45. Westfall J.M., Mold J., Fagnan L. Practice-based research-'blue highways' on the NIH roadmap. JAMA 2007, 297:403-406.
46. Windrum P., Garcia-Goni M. A neo-schumpeterian model of health services innovation. Research Policy 2008, 37:649-672.